Research statistics

Teriparatide research: publications and trials

What has been published on Teriparatide: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Teriparatide works or is safe. For what it is and what the studies found, see the Teriparatide profile.
Automated weekly refresh · data through November 8, 2026

At a glance

Publications, all years

3,796

Since 1974

Publications in 2026 so far

168

Through November 8, 2026

Human clinical research

35.6%

1,339 of 3,756 classified

Registered clinical trials

162

ClinicalTrials.gov

Randomized controlled trials

317

Publications reporting an RCT in people

Systematic reviews and meta-analyses

148

Preclinical studies

39.8%

1,137 animal · 318 in vitro · 41 computational

Records that only mention it

1,158

Not counted above

Status in the library: FDA-approved. 40 publications are not yet classified by study type.

What to keep in mind

  • Some completed trials have neither posted results nor a linked results publication.

Publications by year

Teriparatide publications by year and evidence

1974, Human clinical research: 1 of 11975, Preclinical (animal, in vitro, computational): 2 of 21976, Preclinical (animal, in vitro, computational): 1 of 11977, Preclinical (animal, in vitro, computational): 1 of 11978, Human clinical research: 1 of 21978, Preclinical (animal, in vitro, computational): 1 of 21979, Other and not yet classified: 1 of 11980, Human clinical research: 2 of 61980, Preclinical (animal, in vitro, computational): 3 of 61980, Other and not yet classified: 1 of 61981, Human clinical research: 3 of 141981, Preclinical (animal, in vitro, computational): 8 of 141981, Other and not yet classified: 3 of 141982, Human clinical research: 2 of 241982, Preclinical (animal, in vitro, computational): 16 of 241982, Reviews and meta-analyses: 3 of 241982, Other and not yet classified: 3 of 241983, Human clinical research: 1 of 211983, Preclinical (animal, in vitro, computational): 18 of 211983, Reviews and meta-analyses: 1 of 211983, Other and not yet classified: 1 of 211984, Human clinical research: 7 of 281984, Preclinical (animal, in vitro, computational): 20 of 281984, Other and not yet classified: 1 of 281985, Human clinical research: 4 of 311985, Preclinical (animal, in vitro, computational): 25 of 311985, Other and not yet classified: 2 of 311986, Human clinical research: 4 of 431986, Preclinical (animal, in vitro, computational): 37 of 431986, Other and not yet classified: 2 of 431987, Human clinical research: 3 of 341987, Preclinical (animal, in vitro, computational): 26 of 341987, Reviews and meta-analyses: 1 of 341987, Other and not yet classified: 4 of 341988, Human clinical research: 5 of 491988, Preclinical (animal, in vitro, computational): 42 of 491988, Reviews and meta-analyses: 1 of 491988, Other and not yet classified: 1 of 491989, Human clinical research: 5 of 461989, Preclinical (animal, in vitro, computational): 39 of 461989, Reviews and meta-analyses: 1 of 461989, Other and not yet classified: 1 of 461990, Human clinical research: 4 of 411990, Preclinical (animal, in vitro, computational): 37 of 411991, Human clinical research: 6 of 571991, Preclinical (animal, in vitro, computational): 49 of 571991, Other and not yet classified: 2 of 571992, Human clinical research: 4 of 391992, Preclinical (animal, in vitro, computational): 32 of 391992, Other and not yet classified: 3 of 391993, Human clinical research: 9 of 491993, Preclinical (animal, in vitro, computational): 39 of 491993, Reviews and meta-analyses: 1 of 491994, Human clinical research: 3 of 481994, Preclinical (animal, in vitro, computational): 43 of 481994, Other and not yet classified: 2 of 481995, Human clinical research: 3 of 541995, Preclinical (animal, in vitro, computational): 49 of 541995, Reviews and meta-analyses: 1 of 541995, Other and not yet classified: 1 of 541996, Human clinical research: 7 of 381996, Preclinical (animal, in vitro, computational): 30 of 381996, Other and not yet classified: 1 of 381997, Human clinical research: 7 of 401997, Preclinical (animal, in vitro, computational): 33 of 401998, Human clinical research: 5 of 401998, Preclinical (animal, in vitro, computational): 33 of 401998, Reviews and meta-analyses: 1 of 401998, Other and not yet classified: 1 of 401999, Human clinical research: 3 of 421999, Preclinical (animal, in vitro, computational): 37 of 421999, Reviews and meta-analyses: 1 of 421999, Other and not yet classified: 1 of 422000, Human clinical research: 3 of 412000, Preclinical (animal, in vitro, computational): 34 of 412000, Reviews and meta-analyses: 2 of 412000, Other and not yet classified: 2 of 412001, Human clinical research: 5 of 382001, Preclinical (animal, in vitro, computational): 28 of 382001, Reviews and meta-analyses: 2 of 382001, Other and not yet classified: 3 of 382002, Human clinical research: 1 of 302002, Preclinical (animal, in vitro, computational): 23 of 302002, Reviews and meta-analyses: 4 of 302002, Other and not yet classified: 2 of 302003, Human clinical research: 14 of 592003, Preclinical (animal, in vitro, computational): 20 of 592003, Reviews and meta-analyses: 8 of 592003, Other and not yet classified: 17 of 592004, Human clinical research: 11 of 712004, Preclinical (animal, in vitro, computational): 28 of 712004, Reviews and meta-analyses: 20 of 712004, Other and not yet classified: 12 of 712005, Human clinical research: 19 of 822005, Preclinical (animal, in vitro, computational): 28 of 822005, Reviews and meta-analyses: 27 of 822005, Other and not yet classified: 8 of 822006, Human clinical research: 16 of 852006, Preclinical (animal, in vitro, computational): 29 of 852006, Reviews and meta-analyses: 32 of 852006, Other and not yet classified: 8 of 852007, Human clinical research: 28 of 842007, Preclinical (animal, in vitro, computational): 27 of 842007, Reviews and meta-analyses: 22 of 842007, Other and not yet classified: 7 of 842008, Human clinical research: 30 of 922008, Preclinical (animal, in vitro, computational): 26 of 922008, Reviews and meta-analyses: 22 of 922008, Other and not yet classified: 14 of 922009, Human clinical research: 36 of 842009, Preclinical (animal, in vitro, computational): 29 of 842009, Reviews and meta-analyses: 15 of 842009, Other and not yet classified: 4 of 842010, Human clinical research: 44 of 922010, Preclinical (animal, in vitro, computational): 25 of 922010, Reviews and meta-analyses: 19 of 922010, Other and not yet classified: 4 of 922011, Human clinical research: 58 of 1382011, Preclinical (animal, in vitro, computational): 28 of 1382011, Reviews and meta-analyses: 39 of 1382011, Other and not yet classified: 13 of 1382012, Human clinical research: 50 of 1222012, Preclinical (animal, in vitro, computational): 24 of 1222012, Reviews and meta-analyses: 36 of 1222012, Other and not yet classified: 12 of 1222013, Human clinical research: 65 of 1332013, Preclinical (animal, in vitro, computational): 31 of 1332013, Reviews and meta-analyses: 22 of 1332013, Other and not yet classified: 15 of 1332014, Human clinical research: 51 of 1312014, Preclinical (animal, in vitro, computational): 31 of 1312014, Reviews and meta-analyses: 41 of 1312014, Other and not yet classified: 8 of 1312015, Human clinical research: 82 of 1552015, Preclinical (animal, in vitro, computational): 43 of 1552015, Reviews and meta-analyses: 19 of 1552015, Other and not yet classified: 11 of 1552016, Human clinical research: 71 of 1452016, Preclinical (animal, in vitro, computational): 34 of 1452016, Reviews and meta-analyses: 32 of 1452016, Other and not yet classified: 8 of 1452017, Human clinical research: 67 of 1582017, Preclinical (animal, in vitro, computational): 49 of 1582017, Reviews and meta-analyses: 35 of 1582017, Other and not yet classified: 7 of 1582018, Human clinical research: 56 of 1342018, Preclinical (animal, in vitro, computational): 47 of 1342018, Reviews and meta-analyses: 26 of 1342018, Other and not yet classified: 5 of 1342019, Human clinical research: 69 of 1462019, Preclinical (animal, in vitro, computational): 39 of 1462019, Reviews and meta-analyses: 28 of 1462019, Other and not yet classified: 10 of 1462020, Human clinical research: 66 of 1592020, Preclinical (animal, in vitro, computational): 45 of 1592020, Reviews and meta-analyses: 37 of 1592020, Other and not yet classified: 11 of 1592021, Human clinical research: 69 of 1412021, Preclinical (animal, in vitro, computational): 34 of 1412021, Reviews and meta-analyses: 35 of 1412021, Other and not yet classified: 3 of 1412022, Human clinical research: 72 of 1412022, Preclinical (animal, in vitro, computational): 41 of 1412022, Reviews and meta-analyses: 25 of 1412022, Other and not yet classified: 3 of 1412023, Human clinical research: 46 of 1212023, Preclinical (animal, in vitro, computational): 38 of 1212023, Reviews and meta-analyses: 33 of 1212023, Other and not yet classified: 4 of 1212024, Human clinical research: 62 of 1292024, Preclinical (animal, in vitro, computational): 28 of 1292024, Reviews and meta-analyses: 28 of 1292024, Other and not yet classified: 11 of 1292025, Human clinical research: 84 of 1652025, Preclinical (animal, in vitro, computational): 35 of 1652025, Reviews and meta-analyses: 28 of 1652025, Other and not yet classified: 18 of 1652026 (to date), Human clinical research: 75 of 1682026 (to date), Preclinical (animal, in vitro, computational): 31 of 1682026 (to date), Reviews and meta-analyses: 44 of 1682026 (to date), Other and not yet classified: 18 of 168Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified05010015020019741985199620072026*
Counted PubMed publications by year of first publication. * 2026 runs to November 8, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
197410001
197502002
197601001
197701001
197811002
197900011
198023016
1981380314
19822163324
19831181121
19847200128
19854250231
19864370243
19873261434
19885421149
19895391146
19904370041
19916490257
19924320339
19939391049
19943430248
19953491154
19967300138
19977330040
19985331140
19993371142
20003342241
20015282338
20021234230
2003142081759
20041128201271
2005192827882
2006162932885
2007282722784
20083026221492
2009362915484
2010442519492
201158283913138
201250243612122
201365312215133
20145131418131
201582431911155
20167134328145
20176749357158
20185647265134
201969392810146
202066453711159
20216934353141
20227241253141
20234638334121
202462282811129
202584352818165
2026 (to date)75314418168

Study types

Animal study1,137
Review544
Observational human study457
Case report355
In vitro study318
Randomized controlled trial317
Editorial, letter or other217
Other clinical trial210
Meta-analysis89
Systematic review59
Computational study41
Not yet classified40
Guideline or consensus12

Research areas

From MeSH major topics. A paper can be in several areas.

Musculoskeletal2,862
Metabolic health1,568
Tissue repair928
Endocrinology678
Reproductive and sexual health154
Cardiovascular117
Oncology108
Immune system80
Neurological and mental health70
Longevity and aging49
Gastrointestinal35
Dermatology26

Registered clinical trials

35 of 94 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 113 · Unknown status: 17 · Terminated: 11 · Active, not recruiting: 5 · Recruiting: 5 · Withdrawn: 5 · Not yet recruiting: 3 · Enrolling by invitation: 2 · Suspended: 1
Phase not applicable: 27 · Phase 1: 14 · Phase 1 / Phase 2: 2 · Phase 2: 39 · Phase 2 / Phase 3: 2 · Phase 3: 32 · Phase 4: 46

TrialStatusPhaseStartedResults
PROactive HEALing in High-Risk Pelvic and Non-hip Lower Extremity Fragility Fractures (PRO HEAL Pilot)NCT06303284 · 54 enrolledNot yet recruitingPhase 1, Phase 22027-03—
A Study of B-3E07 and Forsteo® in Healthy Adult Female ParticipantsNCT07497503 · 48 enrolledRecruitingPhase 12026-04—
Bone Turnover Markers and Treatment Efficacy in Postmenopausal OsteoporosisNCT07242612 · 40 enrolledCompletedPhase not applicable2025-10—
To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of FractureNCT06898060 · 282 enrolledNot yet recruitingPhase 32025-06—
Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal OsteoporosisNCT06951776 · 28 enrolledNot yet recruitingPhase not applicable2025-05—
Combined Anabolic TherapyNCT06558188 · 50 enrolledRecruitingPhase 42025-02—
A Study of TeriQ Patch in Healthy Adult Female ParticipantsNCT06644040 · 24 enrolledCompletedPhase 12024-10—
Precision Medicine Approach for Osteoporosis - Follow Up StudyNCT06264609 · 40 enrolledEnrolling by invitationPhase 42024-02—
Sequential Therapies After Osteoanabolic TreatmentNCT06164795 · 150 enrolledRecruitingPhase not applicable2023-11—
Teriparatide on Maxillary Sinus Floor OsseointegrationNCT06061354 · 42 enrolledUnknown statusPhase 42023-08—
Study of the Key Techniques of Prevention and Treatment of Osteoporotic RefractureNCT05866029 · 2,478 enrolledRecruitingPhase not applicable2023-05—
Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous ForteoNCT05965167 · 45 enrolledCompletedPhase 12023-05—
Fracture Recovery for Returning to Duty (Teriparatide STRONG)NCT04589819 · 183 enrolledEnrolling by invitationPhase 42022-12—
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone TurnoverNCT05151484 · 60 enrolledActive, not recruitingPhase 42022-03—
Study Evaluating PK of PTH Administered Orally Via RaniPill™ CapsuleNCT05164614 · 50 enrolledCompletedPhase 12022-02—
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney DiseaseNCT04522622 · 48 enrolledRecruitingPhase 42021-12—
To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture RiskNCT07028320 · 493 enrolledCompletedPhase 32021-12—
Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal WomenNCT04974723 · 22,054 enrolledCompletedPhase not applicable2021-07Posted
Weekly Use of Teriparatide to Accelerate Healing of Distal Radius FractureNCT04473989 · 80 enrolledUnknown statusPhase 22021-06—
Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between SexesNCT04921124 · 30 enrolledCompletedPhase 32021-05—
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).NCT04750460 · 20 enrolledCompletedPhase 32021-03—
Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and AgingNCT04669782 · 99 enrolledTerminatedPhase not applicable2020-11—
Replication of the VERO Osteoporosis Trial in Healthcare Claims DataNCT04879420 · 12,757 enrolledCompletedPhase not applicable2020-10—
Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression FractureNCT05018637 · 30 enrolledUnknown statusPhase 22020-09—
Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese AdultsNCT04747392 · 64 enrolledCompletedPhase 12020-08—
Study of Teriparatide in Stress Fracture HealingNCT04196855 · 136 enrolledUnknown statusPhase 32019-12—
Bone Modeling Effects of Combined Anabolic/Antiresorptive AdministrationNCT04026256 · 37 enrolledCompletedPhase 42019-09Posted
Novel Combination Therapy for Osteoporosis in MenNCT03994172 · 40 enrolledCompletedPhase 42019-07Posted
A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone MassNCT04003467 · 161 enrolledCompletedPhase 22019-06—
Circulating Myokine Levels and Bone MetabolismNCT04206618 · 220 enrolledCompletedPhase not applicable2019-06—
Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion SurgeryNCT03770338 · 192 enrolledActive, not recruitingPhase not applicable2019-03—
Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab TherapyNCT03702140 · 90 enrolledUnknown statusPhase 22018-10—
G56W1 in Women With Postmenopausal OsteoporosisNCT03720886 · 148 enrolledUnknown statusPhase 1, Phase 22018-10—
Oral PTH(1-34) PK and PD Study in Patients With HypoparathyroidismNCT03516773 · 20 enrolledCompletedPhase 22018-06—
Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary HypoparathyroidismNCT02824718 · 16 enrolledCompletedPhase 22017-06—
The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNANCT03133195 · 50 enrolledCompletedPhase 32017-05—
PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled TrialNCT02972424 · 35 enrolledCompletedPhase 22017-05Posted
Teriparatide as a Chondroregenerative Therapy in OANCT03072147 · 76 enrolledCompletedPhase 22017-05—
MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal OsteoporosisNCT03472846 · 26 enrolledCompletedPhase 42017-03—
Effectiveness or Orthopedic Intervention in Osteoporosis Management After a Fracture of the Hip With Cost-Benefit AnalysisNCT02239523 · 200 enrolledCompletedPhase not applicable2017-02—
Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVPNCT03692143 · 90 enrolledActive, not recruitingPhase not applicable2017-01—
A Comparison of PF708 and Forteo in Osteoporosis PatientsNCT03002428 · 181 enrolledCompletedPhase 32016-12—
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic AcidNCT03735537 · 350 enrolledCompletedPhase 42016-11—
Ankle Fractures Treated With TeriparatideNCT02955056 · 10 enrolledUnknown statusPhase 42016-10—
A Comparison Study of PF708 and Forteo in Healthy SubjectsNCT02656810 · 70 enrolledCompletedPhase 12015-12—
PTH and Vibration in OSteoporosis StudyNCT02563353 · 35 enrolledCompletedPhase not applicable2015-11—
Renal Osteodystrophy: An Individual Management ApproachNCT02440581 · 141 enrolledCompletedPhase not applicable2015-07Posted
A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo PenNCT02478879 · 24 enrolledCompletedPhase 12015-06—
Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis MedicationNCT02472782 · 851 enrolledCompletedPhase not applicable2015-05—
One Week Comparison Study of PTH and PTHrP InfusionsNCT01333267WithdrawnPhase 12015-01—

The 50 most recently started of 162 trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Perioperative Anabolic Osteoporosis Pharmacotherapy is Associated with Lower Rates of Proximal Junctional Kyphosis After Adult Spinal Deformity Surgery: A Systematic Review and Meta-Analysis.

    Spine · August 17, 2026 · Meta-analysis · cited 0 times

    PMID 42611824 · DOI 10.1097/brs.0000000000005831 · Reviews and meta-analyses

  2. Teriparatide Therapy in Children with Hypoparathyroidism: A Systematic Review and Meta-Analysis.

    Calcified tissue international · July 25, 2026 · Meta-analysis · cited 0 times · open access

    PMID 42501079 · DOI 10.1007/s00223-026-01582-y · Reviews and meta-analyses

  3. Influence of bisphosphonate pretreatment on bone mineral density gains and fracture outcomes with teriparatide: A systematic review and meta-analysis.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · July 15, 2026 · Meta-analysis · cited 0 times

    PMID 42455318 · DOI 10.1007/s00198-026-08136-w · Reviews and meta-analyses

  4. Artificial Intelligence for Evidence Synthesis of Emerging Biologics to Improve Skeletal Health in Osteogenesis Imperfecta: Systematic Review and Meta-Analysis.

    Journal of medical Internet research · July 10, 2026 · Meta-analysis · cited 0 times · open access

    PMID 42430720 · DOI 10.2196/85840 · Reviews and meta-analyses

  5. The effects of anti-osteoporotic medication on fracture healing and outcomes: a systematic review and meta-analysis.

    The lancet. Healthy longevity · May 1, 2026 · Meta-analysis · cited 1 times · open access

    PMID 42229491 · DOI 10.1016/j.lanhl.2026.100827 · Reviews and meta-analyses

  6. The Anabolic-First Strategy in Osteoporosis: A Systematic Review and Meta-Analysis of Fracture Outcomes in Patients at Very High Fracture Risk.

    Medicina (Kaunas, Lithuania) · April 3, 2026 · Meta-analysis · cited 2 times · open access

    PMID 42075559 · DOI 10.3390/medicina62040687 · Reviews and meta-analyses

  7. Romosozumab Versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: An Overview of Systematic Reviews With Direct and Indirect Meta-Analyses.

    International journal of rheumatic diseases · April 1, 2026 · Meta-analysis · cited 0 times · open access

    PMID 41999058 · DOI 10.1111/1756-185x.70658 · Reviews and meta-analyses

  8. Effect of teriparatide on improving fracture union in osteoporotic intertrochanteric fractures: A systematic review and meta-analysis.

    World journal of orthopedics · February 18, 2026 · Meta-analysis · cited 2 times · open access

    PMID 41695727 · DOI 10.5312/wjo.v17.i2.113659 · Reviews and meta-analyses

  9. Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.

    Frontiers in endocrinology · January 19, 2026 · Meta-analysis · cited 2 times · open access

    PMID 41635538 · DOI 10.3389/fendo.2025.1732708 · Reviews and meta-analyses

  10. Effectiveness of treatments to prevent femoral periprosthetic bone loss following total hip arthroplasty: a network meta-analysis.

    Frontiers in pharmacology · November 27, 2025 · Meta-analysis · cited 2 times · open access

    PMID 41394160 · DOI 10.3389/fphar.2025.1566890 · Reviews and meta-analyses

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

    The New England journal of medicine · May 1, 2001 · Randomized controlled trial · cited 4,604 times

    PMID 11346808 · DOI 10.1056/nejm200105103441904 · Human clinical research

  2. Osteoporosis.

    Lancet (London, England) · January 1, 2019 · Review · cited 2,428 times

    PMID 30696576 · DOI 10.1016/s0140-6736(18)32112-3 · Reviews and meta-analyses

  3. Romosozumab in postmenopausal women with low bone mineral density.

    The New England journal of medicine · January 1, 2014 · Randomized controlled trial · cited 1,258 times

    PMID 24382002 · DOI 10.1056/nejmoa1305224 · Human clinical research

  4. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

    The Journal of clinical investigation · August 1, 1999 · Animal study · cited 1,043 times · open access

    PMID 10449436 · DOI 10.1172/jci6610 · Animal studies

  5. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

    The New England journal of medicine · November 1, 2007 · Randomized controlled trial · cited 915 times · open access

    PMID 18003959 · DOI 10.1056/nejmoa071408 · Human clinical research

Latest publications

  1. Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: A real-world propensity score-matched cohort study.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · November 2, 2026 · Editorial, letter or other · cited 0 times

    PMID 42970159 · DOI 10.1007/s00198-026-08291-0 · Commentary and other

  2. Parathyroid Hormone for Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis.

    Oral diseases · November 1, 2026 · Review · cited 0 times

    PMID 42967897 · DOI 10.1111/odi.70551 · Reviews and meta-analyses

  3. Combined Teriparatide and Exercise Effects on Diabetic Skeletal Muscle Ultrastructure.

    In vivo (Athens, Greece) · November 1, 2026 · Animal study · cited 0 times

    PMID 42957250 · DOI 10.21873/invivo.14495 · Animal studies

  4. Bone Anabolic Treatment in Patients With Chronic Kidney Disease: A Systematic Review.

    Basic & clinical pharmacology & toxicology · November 1, 2026 · Systematic review · cited 0 times · open access

    PMID 42825520 · DOI 10.1111/bcpt.70293 · Reviews and meta-analyses

  5. Teriparatide Topical Delivery Supports Osseointegration in Ovariectomized Rats Receiving Cafeteria Diet and Bisphosphonate: An In Vivo Experimental Study.

    Clinical oral implants research · October 26, 2026 · Animal study · cited 0 times

    PMID 42931806 · DOI 10.1111/clr.70187 · Animal studies

  6. Contralateral atypical femoral fracture following a single dose of denosumab after incomplete teriparatide therapy in a patient with long-term bisphosphonate exposure: A case report.

    Bone reports · October 24, 2026 · Case report · cited 0 times

    PMID 42965087 · DOI 10.1016/j.bonr.2026.101965 · Human clinical research

  7. Beyond antifracture efficacy: Osteoanabolic versus antiresorptive therapy for chronic pain after osteoporotic vertebral fractures. A systematic review and meta-analysis.

    Bone · October 21, 2026 · Review · cited 0 times

    PMID 42906675 · DOI 10.1016/j.bone.2026.118142 · Reviews and meta-analyses

  8. Bone-targeting engineered exosomes delivering teriparatide mRNA for the treatment of osteoporosis.

    Regenerative therapy · October 16, 2026 · Animal study · cited 0 times · open access

    PMID 42926909 · DOI 10.1016/j.reth.2026.101185 · Animal studies

  9. Response to "Interpreting bone turnover responses and treatment persistence with once-weekly teriparatide".

    Journal of orthopaedic translation · October 13, 2026 · Editorial, letter or other · cited 0 times

    PMID 42903896 · DOI 10.1016/j.jot.2026.101226 · Commentary and other

  10. Case Report: Atypical femoral fractures in adult-onset hypophosphatasia treated with low-dose asfotase alfa and adjunctive teriparatide therapy.

    Frontiers in endocrinology · October 8, 2026 · Case report · cited 0 times · open access

    PMID 42871899 · DOI 10.3389/fendo.2026.1909920 · Human clinical research

Browse all 3,796 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Bonsity; Forsteo; Forteo; Parathar; PTH (1-34); Teriparatida; Teriparatide; Teriparatidum

((TITLE_ABS:"Bonsity" OR CHEM:"Bonsity") OR (TITLE_ABS:"Forsteo" OR CHEM:"Forsteo") OR (TITLE_ABS:"Forteo" OR CHEM:"Forteo") OR (TITLE_ABS:"Parathar" OR CHEM:"Parathar") OR (TITLE_ABS:"PTH (1-34)" OR CHEM:"PTH (1-34)") OR (TITLE_ABS:"Teriparatida" OR CHEM:"Teriparatida") OR (TITLE_ABS:"Teriparatide" OR CHEM:"Teriparatide") OR (TITLE_ABS:"Teriparatidum" OR CHEM:"Teriparatidum")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 9). Teriparatide research statistics (Version weekly-2026-11-08) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/teriparatide